Boccaccio, Carla,Comoglio, Paolo Maria,Petronzelli, Fiorella,Santis, Rita de
申请号:
AU2012201303
公开号:
AU2012201303A1
申请日:
2012.03.02
申请国别(地区):
AU
年份:
2012
代理人:
摘要:
#$%^&*AU2012201303A120121004.pdf#####ABSTRACT Met inhibitor and/or nucleotide sequence encoding a Met inhibitor for use in the treatment of patients 5 suffering from a cancer for reducing and/or abrogating patients' resistance to radiotherapy, wherein the Met inhibitor is selected among: i) an anti-Met monoclonal antibody, ii) a genetically engineered antibody containing the complementarity determining regions 10 (CDRs) of the anti-Met monoclonal antibody, and iii) a fragment of (i) or (ii) containing the complementarity determining regions (CDRs) of the anti-Met monoclonal antibody, or combinations thereof. 15 (Figure 5)